MCOLN1 and breast carcinoma: These results suggest that salinomycin can modulate lysosomal iron homeostasis by acting on TRPML1 channels in breast cancer cells and CSCs, highlighting the potential of TRPML1 as an intervention site for breast cancer therapy.